Biomea Fusion (BMEA) vs OnKure Therapeutics (OKUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OnKure Therapeutics (OKUR) has outperformed Biomea Fusion (BMEA) over the past year, losing 21.4% versus a loss of 28.5%. Over five years, BMEA leads with a -88.7% price change compared with -96.4% for OKUR. Biomea Fusion is the larger company by market cap ($95.4 million vs $95.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BMEA | OKUR |
|---|---|---|
| Share price | $1.32 | $2.35 |
| Market cap | $95.44M | $95.17M |
| 1-day change | +5.60% | -4.47% |
| YTD return | +6.45% | -18.97% |
| 1-year return | -28.46% | -21.40% |
| 5-year return | -88.65% | -96.35% |
| EPS (TTM) | $-0.29 | $-3.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.24 | $5.38 |
| 52-week low | $0.872 | $2.23 |
| Distance from 52-week high | -40.99% | -56.32% |
| Average volume | 1.47M | 211.44K |
| Shares outstanding | 72.30M | 40.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BMEA vs OKUR FAQ
Which is bigger, Biomea Fusion or OnKure Therapeutics?
Biomea Fusion (BMEA) is larger, with a market capitalization of $95.44M compared with $95.17M for OnKure Therapeutics (OKUR).
Which stock has performed better over the past year, BMEA or OKUR?
OKUR returned -21.40% over the past 12 months, compared with -28.46% for BMEA (price return, excluding dividends). Past performance does not predict future results.
Are Biomea Fusion and OnKure Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.